Indrayani Biotech Share Price

Small Cap | Hospitality | BSE: 526445

₹20.89 image-0.30 (-1.42 %)

Last Updated: 28 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 20.85

High (₹) 21.54

Low (₹) 19.08

Prev. Close (₹) 21.19

Volume 92,776

VWAP (₹) 19.89

ROCE (%) 14.09

Industry P/E 80.96

TTM P/E 15.36

P/B Ratio 1.25

Market Cap (₹) Cr.95.13

Dividend Yield (%)--

EPS (₹) 1.63

ROE9.73%

Sales Growth (%) 2.02

Profit Growth (%)-12.64

Day Range

21.5421.54

L
H

52 Week Range

19.0866.80

L
H

Historical Returns

Returns (6M)

-54.92 %

Returns (1Y)

-67.89 %

Returns (3Y)

9.66 %

Returns (5Y)

150.18 %

Returns (6M)

-54.92 %

Returns (1Y)

-67.89 %

Returns (3Y)

9.66 %

Returns (5Y)

150.18 %

SWOT Analysis

  • Book value per share improving over the last 2 years
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 53.06

MFI 38.68

ATR 2.22

Commodity Channel Index -140.20

ROC125 -58.04

ROC21 -34.34

Williams %R -90.86

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current21.2422.6223.7020.1618.7817.7016.32
Week Ago24.5225.9027.0223.4022.0220.9019.52
Month Ago31.9433.3134.9330.3228.9527.3325.96

EMA & SMA
info_icon

20.89

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 22.12


9 Day 22.94


10 Day 22.71


12 Day 23.12


14 Day 23.60

20 Day 25.14


26 Day 26.46


50 Day 30.45


100 Day 34.98


200 Day 43.05

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
TOPGAIN FINANCE PRIVATE LIMITEDbulkSell27 Jun, 2024₹58.601,37,325BSE
SAHASTRAA ADVISORS PRIVATE LIMITEDbulkSell27 Jun, 2024₹58.602,67,714BSE
NEXT ORBIT VENTURES FUNDbulkSell27 Jun, 2024₹58.8610,00,000BSE
TOPGAIN FINANCE PRIVATE LIMITEDbulkBuy27 Jun, 2024₹59.463,51,626BSE
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDbulkBuy27 Jun, 2024₹58.609,52,945BSE
SAHASTRAA ADVISORS PRIVATE LIMITEDbulkBuy26 Jun, 2024₹59.112,67,714BSE
NEXT ORBIT VENTURES FUNDbulkSell05 Jul, 2023₹63.422,00,000BSE
BOUGAINVILLEA INVESTMENTS PRIVATE LIMITEDbulkSell04 Jul, 2023₹62.501,93,747BSE
NEXT ORBIT VENTURES FUNDbulkSell14 Sept, 2022₹105.142,98,475BSE
NEXT ORBIT VENTURES FUNDbulkSell30 Aug, 2022₹70.484,00,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
01 Jul, 2022V AgathiyanDisposal₹20.0010,25,000BSE
01 Jul, 2022Thirumeni ThiruselvarajuDisposal₹20.003,09,389BSE
14 Mar, 2022Thirumeni ThiruselvarajaDisposal₹19.273,91,000BSE
08 Jan, 2021Singarababu IndirakumarAcquisition₹0.0020,98,600BSE
08 Jan, 2021G.SwaminathanAcquisition₹0.0041,40,000BSE
08 Jan, 2021Sayee Sundar KasiramanAcquisitionBSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
28 Feb, 2025BSE IndiaClarification letter on delay in submission of unaudited financial results for the quarter and nine months ended December 31, 2024 is attached.
27 Feb, 2025BSE IndiaIntegrated filling (Financial) for the quarter ended 31, December 2024
27 Feb, 2025BSE IndiaFinancial results and Limited review report for the quarter and nine months ended 31, December 2024
26 Feb, 2025BSE IndiaINDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/02/2025 ,inter alia, to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business. \r\n\r\nA Board meeting for considering the said financial results was conducted on 14-02-2025 for which due intimation was given on 10-02-2025. That Board meeting could not consider said financial results since the financial statements of the material subsidiaries could not be consolidated due to unforeseen\r\ncircumstances. The said financial results is being considered at an adjourned meeting to be held on 27-02-2024. While giving this intimation to Stock Exchange there is no provision to choose adjourned meeting in the given descriptions hence we have chosen Board meeting rescheduled in the description. Therefore we request you to kindly take note of the adjourned Board meeting.
14 Feb, 2025BSE IndiaIntimation of adjournment of Board meeting and closure of trading window
10 Feb, 2025BSE IndiaINDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business.
02 Jan, 2025BSE IndiaThe name of Company''s Registrar and Transfer Agent, M/s. Link Intime India Private Limited, has been changed to M/s. MUFG Intime India Private Limited with effect from 31.12.2024
17 Dec, 2024BSE IndiaThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 16, 2024 for Swaminathan
15 Nov, 2024BSE IndiaThe proposal of rights issue of equity shares as attached.
15 Nov, 2024BSE IndiaResults

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--28 Feb, 202527 Feb, 2025
Quarterly Results(BM Adjourned)20 Feb, 202514 Feb, 2025
Quarterly Results & Rights issue--12 Nov, 202414 Nov, 2024
Quarterly Results--09 Aug, 202414 Aug, 2024
OthersInter alia, To fix the date, time, venue and mode of 32ndAnnual General Meeting of the Company and approve the draft Notice for convening the said General Meeting.25 Jul, 202427 Jul, 2024
Audited Results--24 May, 202430 May, 2024
Quarterly Results--06 Feb, 202410 Feb, 2024
Increase in Authorised Capital--09 Jan, 202410 Jan, 2024
Quarterly Results--10 Nov, 202314 Nov, 2023
Dividend on Pref shares & OthersInter alia, to consider and approve the allotment of Equity shares by conversion of Compulsorily Convertible Preference Shares subject to lock in period of 6 months.28 Oct, 202301 Nov, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Apr, 2024Mar, 2024Dec, 2023

About Indrayani Biotech

Indrayani Biotech is a Public Limited Listed company incorporated on 09/03/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L40100TN1992PLC129301 and registration number is 065801. Currently company belongs to the Industry of Hotels, Resorts & Restaurants. Company’s Total Operating Revenue is Rs. 62.32 Cr. and Equity Capital is Rs. 45.54 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Not Applicable

Founded

1992

Managing Director

Mr. Kasiraman Sayee Sundar

NSE Symbol

--

Indrayani Biotech Management

NameDesignation
Mr. Nangavaram Mahadevan RanganathanChairman
Mr. Kasiraman Sayee SundarManaging Director
Mr. Singarababu IndirakumarDirector
Mr. G SwaminathanDirector
Mr. Muthukrishnan RameshDirector
Mr. Kannimangalam Subramanyan VaidyanathanDirector
Mrs. Lakshmiprabha KasiramanDirector
Dr. Bokara Nagarajan Padmaja PriyadarshiniDirector

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
IndianHotels₹1,22,500.58₹716.10 image
₹724.35(-1.14%)
₹429.300 - ₹887.600
JubilantFood₹46,723.64₹626.10 image
₹670.90(-6.68%)
₹420.850 - ₹724.950
EIH₹25,718.10₹319.25 image
₹329.60(-3.14%)
₹241.800 - ₹566.000
Devyani Int₹23,247.17₹165.02 image
₹173.36(-4.81%)
₹142.050 - ₹222.750
Chalet Hotel₹21,604.69₹737.05 image
₹732.35(0.64%)
₹648.000 - ₹1,051.150

FAQs on Indrayani Biotech

What is the share price of Indrayani Biotech?

The share price of Indrayani Biotech on 28 Feb, 2025 is ₹ 20.89.

What is 52W high and 52W low share price of Indrayani Biotech?

The highest and lowest 52W share prices of Indrayani Biotech are ₹ 99.700 and ₹ 34.020

What is the market cap of Indrayani Biotech?

The market capitalization of Indrayani Biotech as of 28 Feb, 2025 is ₹ 95.13 Crores

What is the P/E ratio of Indrayani Biotech?

The current P/E ratio of Indrayani Biotech as of 28 Feb, 2025 is 80.96

What is the PB ratio of Indrayani Biotech?

The PB ratio of Indrayani Biotech as of 28 Feb, 2025 is 1.25

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited